Susquehanna International Group
VTYX

Susquehanna International Group’s Ventyx Biosciences VTYX Stock Holding History

Susquehanna International Group’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-407,400
Closed -$3.68M – 14205
2025
Q4 		$3.68M Buy
407,400
+380,700
+1,426% +$2.85M ﹤0.01% 4533
2025
Q3 		$83K Sell
26,700
-5,600
-17% -$14.8K ﹤0.01% 11665
2025
Q2 		$69.1K Buy
32,300
+13,100
+68% +$21.2K ﹤0.01% 11994
2025
Q1 		$22.1K Sell
19,200
-69,700
-78% -$120K ﹤0.01% 12088
2024
Q4 		$195K Buy
88,900
+43,800
+97% +$99.3K ﹤0.01% 10753
2024
Q3 		$98.3K Sell
45,100
-157,400
-78% -$362K ﹤0.01% 11061
2024
Q2 		$468K Buy
202,500
+69,900
+53% +$290K ﹤0.01% 8429
2024
Q1 		$729K Buy
132,600
+101,000
+320% +$462K ﹤0.01% 7614
2023
Q4 		$78.1K Sell
31,600
-59,900
-65% -$569K ﹤0.01% 11494
2023
Q3 		$3.18M Sell
91,500
-70,500
-44% -$2.44M ﹤0.01% 4274
2023
Q2 		$5.31M Buy
162,000
+127,000
+363% +$4.38M ﹤0.01% 3423
2023
Q1 		$1.17M Buy
+35,000
New +$1.36M ﹤0.01% 6399
2022
Q4 		– Sell
-35,800
Closed -$1.25M – 13801
2022
Q3 		$1.25M Buy
+35,800
New +$793K ﹤0.01% 6056

Other funds holding VTYX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Susquehanna International Group's VTYX Position: Q1 2026 in Review

Susquehanna International Group sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 1,118,275 shares — an estimated $10.1M sold.

Susquehanna International Group first reported a position in VTYX in Q3 2022 and held it in 12 quarters. The position peaked at $10.1M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Susquehanna International Group reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 1,118,275 Ventyx Biosciences shares in Q1 2026, an estimated $10.1M.
  • Susquehanna International Group first reported a position in Ventyx Biosciences in Q3 2022 and held it in 12 quarters.
  • Susquehanna International Group's Ventyx Biosciences position peaked at $10.1M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.